harmaline has been researched along with Movement Disorders in 2 studies
Harmaline: A beta-carboline alkaloid isolated from seeds of PEGANUM.
harmaline : A harmala alkaloid in which the harman skeleton is methoxy-substituted at C-7 and has been reduced across the 3,4 bond.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, M | 1 |
| Anagnoste, B | 1 |
| Battista, AF | 1 |
| Ogawa, M | 1 |
| Crepel, F | 1 |
| Mariani, J | 1 |
1 review available for harmaline and Movement Disorders
| Article | Year |
|---|---|
Monkeys with nigrostriatal lesions effects of monoaminergic drugs.
Topics: Amino Acids; Animals; Antiparkinson Agents; Apomorphine; Biogenic Amines; Carboxy-Lyases; Catechol O | 1976 |
1 other study available for harmaline and Movement Disorders
| Article | Year |
|---|---|
Anatomical, physiological and biochemical studies of the cerebellum from mutant mice. I. Electrophysiological analysis of cerebellar cortical neurons in the staggerer mouse.
Topics: Animals; Cerebellum; Electrophysiology; Evoked Potentials; Harmaline; Mice; Mice, Inbred Strains; Mo | 1975 |